GenShin:geometry-enhanced structural graph embodies binding pose can better predicting compound-protein interaction affinity

AI-powered drug discovery typically relies on the successful prediction of compound-protein interactions, which are pivotal for the evaluation of designed compound molecules in structure-based drug design and represent a core challenge in the field.However, accurately predicting compound-protein affinity via regression models usually requires adequate-binding pose, which are derived from costly and complex experimental methods or time-consuming simulations with docking software. In response, we have introduced the GenShin model, which constructs a geometry-enhanced structural graph module that separately extracts additional features from proteins and compounds. Consequently, it attains an accuracy on par with mainstream models in predicting compound-protein affinities, while eliminating the need for adequate-binding pose as input. Our experimental findings demonstrate that the GenShin model vastly outperforms other models that rely on non-input docking conformations, achieving, or in some cases even exceeding, the performance of those requiring adequate-binding pose. Further experiments indicate that our GenShin model is more robust to inadequate-binding pose, affirming its higher suitability for real-world drug discovery scenarios. We hope our work will inspire more endeavors to bridge the gap between AI models and practical drug discovery challenges.